IPSC
Price
$1.84
Change
+$1.24 (+206.67%)
Updated
Feb 3 closing price
Capitalization
160.83M
36 days until earnings call
Intraday BUY SELL Signals
ZNTL
Price
$2.82
Change
+$1.01 (+55.80%)
Updated
Feb 3 closing price
Capitalization
162.52M
28 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IPSC vs ZNTL

Header iconIPSC vs ZNTL Comparison
Open Charts IPSC vs ZNTLBanner chart's image
Century Therapeutics
Price$1.84
Change+$1.24 (+206.67%)
Volume$1.74M
Capitalization160.83M
Zentalis Pharmaceuticals
Price$2.82
Change+$1.01 (+55.80%)
Volume$1.13M
Capitalization162.52M
IPSC vs ZNTL Comparison Chart in %
IPSC
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IPSC vs. ZNTL commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a Hold and ZNTL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (IPSC: $1.84 vs. ZNTL: $2.82)
Brand notoriety: IPSC and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 82% vs. ZNTL: 70%
Market capitalization -- IPSC: $160.83M vs. ZNTL: $182.6M
IPSC [@Biotechnology] is valued at $160.83M. ZNTL’s [@Biotechnology] market capitalization is $182.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, ZNTL is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 3 TA indicator(s) are bullish while ZNTL’s TA Score has 5 bullish TA indicator(s).

  • IPSC’s TA Score: 3 bullish, 5 bearish.
  • ZNTL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ZNTL is a better buy in the short-term than IPSC.

Price Growth

IPSC (@Biotechnology) experienced а -30.57% price change this week, while ZNTL (@Biotechnology) price change was -3.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

Reported Earning Dates

IPSC is expected to report earnings on Mar 12, 2026.

ZNTL is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZNTL($163M) and IPSC($161M) have the same market capitalization . ZNTL (85.926) and IPSC (84.962) have similar YTD gains . IPSC has higher annual earnings (EBITDA): -909K vs. ZNTL (-152.83M). ZNTL has more cash in the bank: 281M vs. IPSC (133M). ZNTL has less debt than IPSC: ZNTL (36.7M) vs IPSC (45M). IPSC has higher revenues than ZNTL: IPSC (113M) vs ZNTL (26.9M).
IPSCZNTLIPSC / ZNTL
Capitalization161M163M99%
EBITDA-909K-152.83M1%
Gain YTD84.96285.92699%
P/E RatioN/AN/A-
Revenue113M26.9M420%
Total Cash133M281M47%
Total Debt45M36.7M123%
FUNDAMENTALS RATINGS
ZNTL: Fundamental Ratings
ZNTL
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPSCZNTL
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 14 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IPSC
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PURE0.05N/A
+5.25%
PURE Bioscience
OMRNY25.480.10
+0.39%
OMRON Corp.
VEOEF37.06N/A
N/A
Veolia Environnement
BJTRF0.65N/A
N/A
Beijing Tong Ren Tang Chinese Medicine Co Ltd, Hong Kong
HURRY3.00N/A
N/A
Hurriyet Gazete Tl

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
N/A
CRSP - IPSC
54%
Loosely correlated
+1.34%
FATE - IPSC
50%
Loosely correlated
-5.69%
CABA - IPSC
49%
Loosely correlated
+3.60%
NTLA - IPSC
48%
Loosely correlated
-0.08%
KYTX - IPSC
47%
Loosely correlated
N/A
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with RVMD. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+3.29%
RVMD - ZNTL
48%
Loosely correlated
+0.22%
ERAS - ZNTL
46%
Loosely correlated
+0.95%
CGON - ZNTL
44%
Loosely correlated
+4.40%
NKTX - ZNTL
43%
Loosely correlated
-2.70%
IPSC - ZNTL
42%
Loosely correlated
-3.16%
More